True Private Wealth Advisors Viatris Inc Transaction History

True Private Wealth Advisors

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 28, 2022	BUY	$9.95 - $12.27 $2,935 - $3,619	295 Added 2.41%	12,547 $131,000
Q1 2022 May 09, 2022	SELL	$9.81 - $15.4 $4,993 - $7,838	-509 Reduced 3.99%	12,252 $128,000
Q4 2021 Feb 11, 2022	BUY	$12.09 - $14.68 $6,818 - $8,279	564 Added 4.62%	12,761 $172,000
Q3 2021 Nov 05, 2021	SELL	$13.25 - $15.13 $3,802 - $4,342	-287 Reduced 2.3%	12,197 $165,000
Q2 2021 Aug 10, 2021	SELL	$12.97 - $16.15 $27,470 - $34,205	-2,118 Reduced 14.5%	12,484 $178,000
Q1 2021 May 12, 2021	BUY	$13.59 - $18.54 $31,338 - $42,753	2,306 Added 18.75%	14,602 $204,000
Q4 2020 Jan 11, 2021	BUY	$14.3 - $18.74 $175,832 - $230,427	12,296 New	12,296 $230,000

1,102

933M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.2B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of True Private Wealth Advisors, based on Form 13F filings with the SEC.

Stay updated on True Private Wealth Advisors with notifications on news.